Jeffrey Eisele, Chief Development Officer: Apellis Pharmaceuticals APLS Sell · Filed 24/01/23

Trade details

Type: Insider sale
Amount: $104,455
Shares · price: 1,607 sh · $65.00 a share
Held after: 65,836 sh
Stock: Apellis Pharmaceuticals APLS
Person: Jeffrey EiseleChief Development Officer
Trade date: 24/01/22
Filed: 24/01/23
Days to filing: 1 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Apellis Pharmaceuticals trades, last 26 weeks

What else happened in Apellis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/23~24/02/21

Jeffrey Eisele's recent trades

Jeffrey EiseleChief Development Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$8,207
278 sh
$8,207
Filed 25/01/30
Traded 25/01/29
Jeffrey EiseleChief Development Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$39.3K
1,291 sh
$39.3K
Filed 25/01/23
Traded 25/01/22
Jeffrey EiseleChief Development Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$7,577
264 sh
$7,577
Filed 25/01/14
Traded 25/01/13
Jeffrey EiseleChief Development Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$2,085
63 sh
$2,085
Filed 24/12/27
Traded 24/12/23
Jeffrey EiseleChief Development Officer
Sell10b5-1 planApellis Pharmaceuticals
Sell10b5-1 plan
Apellis Pharmaceuticals
APLS
$63.6K
971 sh
$63.6K
Filed 24/01/31
Traded 24/01/30